Metcela Inc. | Revolutionizing the Way We Treat Heart Failure > NEWS > PRESS RELEASE > Metcela Raised $4 Million in Series B Funding to Launch a Phase I Clinical Trial for Heart Failure Therapy > to Launch a Phase I Clinical Trial for Heart Failure Therapy

2020.06.25

to Launch a Phase I Clinical Trial for Heart Failure Therapy | Metcela Inc. | Revolutionizing the Way We Treat Heart Failure

to Launch a Phase I Clinical Trial for Heart Failure Therapy

NEWS

2024.07.01

Leadership Transition
NEWS

2023.12.06

Metcela to Strengthen Clinical Pipeline Development, New Headquarters and R&D Center at Kawasaki King Skyfront
PRESS RELEASE

2023.09.21

Metcela and Nagoya University to Collaborate in Research to Accelerate the Development of Regenerative Medicine
NEWS

2022.12.08

Metcela Received the Best Research Award at the Well-being & Age-Tech 2022 Award

News archive